() managing director & CEO Sean Hall catches up with Proactive Investors about the biotech's progress so far in 2019.
Hall teases, "We're planning on having around about 3000 pharmacies utilising the Medlab VMS range before this calendar year is out."
Progress is also being made with the NanoCelle drug delivery platform. Clinical and human trials are ongoing for NanaBis and NanoStat. On the back of this, Medlab has been making strong moves into Europe.
Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
Meet Faron Pharmaceuticals Ltd, Belvoir Lettings, Silence Therapeutics PLC, ANGLE PLC and ReNeuron Group PLC at our event,
London , 23 May 2019.
Register here »